Fig. 1From: Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS)Flow diagram of participant inclusion. RAMS Rheumatoid Arthritis Medication Study; MTX, methotrexate; EULAR, European League Against RheumatismBack to article page
